This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Gilead Sciences Inc. slipped 4.3% to $109.64 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.3% to 6,259.75 and Dow Jones Industrial Average falling 0.6% to 44,371.51.
The stock's fall snapped a two-day winning streak.
Gilead Sciences Inc. closed 8.6% below its 52-week high of $119.96, which the company reached on March 10th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 0.5% to $156.90, Pfizer Inc. fell 0.5% to $25.65, and Abbott Laboratories fell 1.18% to $132.02.
Trading volume totaled 6.1 million, compared to the 50-day average of 8.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 11, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.